Apoptosis in the Resolution of Systemic Inflammation

  • J. C. Marshall
  • R. W. G. Watson
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1997)


Admission to a contemporary ICU is precipitated by a heterogeneous group of disease processes, yet the final common pathway to death is strikingly similar [1]. Fully 80% of all ICU deaths occur in association with the multiple organ dysfunction syndrome (MODS) [2], a poorly understood process characterized by the development of progressive physiologic dysfunction in organ systems initially unaffected by the primary disease process. Activation of a host inflammatory response by infection, injury, or ischemia, invariably proceeds the development of MODS [3]. The proximate causes of organ injury are not bacterial products, but the same endogenous host-derived mediators of inflammation that are responsible for containing an infectious challenge and initiating the process of tissue repair. MODS can be conceptualized as the consequence of an overly activated or inappropriately prolonged systemic inflammatory response, therefore an understanding of the mechanisms underlying the resolution of inflammation is important to the development of clinical strategies to prevent the syndrome.


Systemic Inflammatory Response Syndrome Tumor Necrosis Factor Receptor Multiple Organ Dysfunction Syndrome Staphylococcal Enterotoxin Neutrophil Apoptosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Baue AE (1975) Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. Arch Surg 110: 779–781PubMedCrossRefGoogle Scholar
  2. 2.
    Deitch EA (1992) Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216: 117–134PubMedCrossRefGoogle Scholar
  3. 3.
    Marshall JC, Sweeney D (1990) Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome. Arch Surg 125: 17–23PubMedCrossRefGoogle Scholar
  4. 4.
    Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174: 1549–1555PubMedCrossRefGoogle Scholar
  5. 5.
    Arend WP Welgus HG, Thompson RC, Eisenberg SP (1990) Biological properties of recombinant human monocyte derived interleukin-1 receptor antagonist. J Clin Invest 85: 1694–1697PubMedCrossRefGoogle Scholar
  6. 6.
    Haslett C (1992) Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 83: 639–648PubMedGoogle Scholar
  7. 7.
    Gerschenson LE, Rotello RJ (1992) Apoptosis: A different type of cell death. EASES J 6: 2450–2455Google Scholar
  8. 8.
    Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271–276PubMedCrossRefGoogle Scholar
  9. 9.
    Martin SJ, Green DR (1995) Protease activation during apoptosis: Death by a thousand cuts? Cell 82: 349–352PubMedCrossRefGoogle Scholar
  10. 10.
    Nicholson DW, Ali A, Thornberry NA, et al (1995) Identification and inhibition of the ICE/CED3 protease necessary for mammalian apoptosis. Nature 376: 37–43PubMedCrossRefGoogle Scholar
  11. 11.
    Fraser A, Evan G (1996) A license to kill. Cell 85: 781–784PubMedCrossRefGoogle Scholar
  12. 12.
    Nalin CM (1995) Apoptosis research enters the ICE age. Structure 3: 143–145PubMedCrossRefGoogle Scholar
  13. 13.
    Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: A discourse on the Bd-2 family and cell death. Blood 88: 386–401PubMedGoogle Scholar
  14. 14.
    Hannun YA, Obeid LM (1995) Ceramide: An intracellular signal for apoptosis. Trends Biochem Sci 20: 73–77PubMedCrossRefGoogle Scholar
  15. 15.
    Wiegmann K, Schutze K, Machleidt T, Witte D, Kronke M (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005–1015PubMedCrossRefGoogle Scholar
  16. 16.
    Verheij M, Bose R, Xin HL, et al (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75–79PubMedCrossRefGoogle Scholar
  17. 17.
    Eischen CM, Dick CJ, Leibson PJ (1994) Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153: 1947–1954PubMedGoogle Scholar
  18. 18.
    Watson RWG, Rotstein OD, Nathens AB, Dackiw APB, Marshall JC (1996) Thiol-mediated redox regulation of neutrophil apoptosis. Surgery 120: 150–158PubMedCrossRefGoogle Scholar
  19. 19.
    Ohta H, Yatomi Y, Sweeney EA, Hakomori S, Igarashi Y (1994) A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-a in human neutrophils. FEBS Lett 355: 267–270PubMedCrossRefGoogle Scholar
  20. 20.
    Rossi AG, Cousin JM, Dransfield I, Lawson MF, Chilvers ER, Haslett C (1995) Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem Biophys Res Commun 217: 892–899PubMedCrossRefGoogle Scholar
  21. 21.
    Nagata S, Golstein P (1995) The Fas death factor. Science 267: 1449–1456PubMedCrossRefGoogle Scholar
  22. 22.
    Suda T, Nagata S (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179: 873–879PubMedCrossRefGoogle Scholar
  23. 23.
    Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ (1996) Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184: 429–440PubMedCrossRefGoogle Scholar
  24. 24.
    Nagata S, Suda T (1995) Fas and Fas ligand: 1pr and gld mutations. Immunol Today 16: 39–43PubMedCrossRefGoogle Scholar
  25. 25.
    Mountz JD, Baker TJ, Borcherding DR, Bluethmann H, Zhou T, Edwards CK (1995) Increased susceptibility of fas mutant MRL-1pr/lpr mice to Staphylococcal enterotoxin B-induced septic shock. J Immunol 155: 4829–4837PubMedGoogle Scholar
  26. 26.
    Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 806–809PubMedCrossRefGoogle Scholar
  27. 27.
    Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV (1993) A novel domain within the 55 kD TNF receptor signals cell death. Cell 74: 845–853PubMedCrossRefGoogle Scholar
  28. 28.
    Woods KM, Chapes SK (1993) Three distinct cell phenotypes of induced-TNF cytotoxicity and their relationship to apoptosis. J Leuk Biol 53: 37–44Google Scholar
  29. 29.
    Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappaB activation. Cell 81: 495–504PubMedCrossRefGoogle Scholar
  30. 30.
    Ray CA, Black RA, Kronheim SR, et al (1992) Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69: 597–604PubMedCrossRefGoogle Scholar
  31. 31.
    Tewari M, Dixit VM (1995) Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 270: 3255–3260PubMedCrossRefGoogle Scholar
  32. 32.
    Beidler DR, Tewari M, Friesen PD, Poirier G, Dixit VM (1995) The baculovirus p35 protein inhibits Fas-and tumor necrosis factor-induced apoptosis. J Biol Chem 270: 16526–16528PubMedCrossRefGoogle Scholar
  33. 33.
    Rothe M, Pan M, Henzel WJ, Ayres TM, Goeddel DV (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243–1252PubMedCrossRefGoogle Scholar
  34. 34.
    Liston P, Roy N, Tamai K, et al (1996) Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379: 349–353PubMedCrossRefGoogle Scholar
  35. 35.
    Watson RWG, Redmond HP, Wang JH, Condron C, Bouchier-Hays D (1996) Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol 156: 3986–3994PubMedGoogle Scholar
  36. 36.
    Tsuchida H, Takeda Y, Takei H, Shinzawa H, Takahashi T, Sendo F (1995) In vivo regulation of rat neutrophil apoptosis occurring spontaneously or induced with TNF-a or cycloheximide. J Immunol 154: 2403–2412PubMedGoogle Scholar
  37. 37.
    Watson RWG, Rotstein OD, Nathens AB, Parodo J, Marshall JC (1997) Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. J Immunol (In Press)Google Scholar
  38. 38.
    Bone RC, Balk RA, Cerra FB, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644–1655PubMedCrossRefGoogle Scholar
  39. 39.
    Teodorczyk-Injeyan JA, Cembrznska-Nowak M, Lalani S, Peters WJ, Mills GB (1995) Immune deficiency following thermal trauma is associated with apoptotic cell death. J Clin Immunol 15: 318–328PubMedCrossRefGoogle Scholar
  40. 40.
    Chitnis DC, Dickerson C, Munster AM, Winchurch RA (1996) Inhibition of apoptosis in polymorphonuclear neutrophils from burn patients. J Leuk Biol 59: 835–839Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • J. C. Marshall
  • R. W. G. Watson

There are no affiliations available

Personalised recommendations